LifeMD, Inc. — Director's Dealing 2018

May 24, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Immudyne, Inc. (IMMD)
CIK: 0000948320
Period of Report: 2018-05-22

Reporting Person: Schreiber Justin (Director, Chief Executive Officer, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-05-22	Common Stock, par value $0.01	P	2400	$0.2338	Acquired	2833593	Indirect
2018-05-22	Common Stock, par value $0.01	P	22600	$0.235	Acquired	2856193	Indirect
2018-05-23	Common Stock, par value $0.01	P	80000	$0.22	Acquired	2936193	Indirect
2018-05-23	Common Stock, par value $0.01	A	1000000	—	Acquired	2375000	Indirect

Footnotes

F1: These shares were purchased on the open market.

F2: These shares were issued to JLS Ventures, LLC pursuant to an advisory agreement by and between the Company and JLS Ventures, LLC for services rendered to the Company.